Skip to content

Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients

Educational Intervention to Reduce Drug-related Hospitalizations and Visits in Emergency Departments in Elderly Primary Health Care Patients - a Cluster-randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01732302
Enrollment
69
Registered
2012-11-22
Start date
2012-11-30
Completion date
2013-09-30
Last updated
2013-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Drug Reaction, Polypharmacy

Keywords

Drug Utilization Review, Aged, Aged, 80 and over, Primary Health Care

Brief summary

The purpose of this study is to determine whether an educational intervention given towards health care providers working in primary health care centers can reduce inappropriate prescribing in the elderly patient and thus reduce number and length of drug-related hospitalizations as well as number of emergency department visits in this patient group.

Detailed description

Inappropriate medication in the elderly patient leads to substantial morbidity, possibly causing up to 20% of hospitalizations in this patient group (1). To improve prescribing and thus reduce undesired drug effects is a great challenge for doctors and nurses in primary health care. Performance of drug utilization reviews is recommended in order to reduce the negative impact of inappropriate prescribing in the elderly. However, scientific evidence on their efficacy is lacking, especially regarding patient-related health outcomes (2,3). Most studies are carried out in inpatient care, making it difficult to draw conclusions regarding primary health care (2). Moreover, studies in this scientific field diverge regarding the content and structure of drug utilization reviews, which implies that comparison between studies becomes challenging, if not impossible. This trial aims at educating health care providers in how to perform drug utilization reviews, and to help them implement theory into practice.

Interventions

OTHEREducational intervention

Primary health care centers (PHCC) in the intervention group will be visited twice by a pharmacist within a period of three months. At the first visit, an educational intervention will focus on two properties: on the one hand, feed-back of actual patient data of the PHCC illustrating the primary-health-care-specific characteristics of inappropriate prescribing in the elderly patient will be given. Education of relevant subjects will be given in relation to detected problems. On the other hand, a clinical routine regarding the performance of drug utilization reviews will be developed in cooperation with the health care providers. At the second visit 3 months later, the developed concept will be critically reviewed and eventually developed further.

Sponsors

Region Stockholm
CollaboratorOTHER_GOV
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* primary health care center in Stockholm County * authorized by Stockholm County Council since at least 3 years * at least 5% of patients attributed to primary health care center are 65 years and older * primary health care center takes care of at least 10 home care patients

Exclusion criteria

* less than 3000 patients listed in primary health care center * primary health care centers where researchers carrying out the present study work

Design outcomes

Primary

MeasureTime frame
Composite outcome: Unplanned hospitalisation or emergency department visit9 months

Secondary

MeasureTime frameDescription
Emergency department visit9 months
Length of hospital stay9 months
All cause mortality9 months
Number of drug utilization reviews9 months
Unplanned hospitalisation9 months
Inappropriate drug use according to national guidelines9 monthssee link
Number of patients with contraindicated drugs regarding renal function9 months
Number of drugs with inappropriate drug dose regarding renal function9 months
Number of drug interactions9 months
Number of patients with polypharmacy9 monthspolypharmacy: 5-9 drugs/patient excessive polypharmacy: 10 and more drugs/patient

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026